HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilie Merlen Selected Research

Emilie Merlen Research Topics

Disease

2Hypothyroidism
08/2022 - 03/2018
2Neoplasms (Cancer)
08/2022 - 03/2018
2Hypophysitis
10/2018 - 03/2018
2Traumatic Brain Injuries (Traumatic Brain Injury)
06/2013 - 01/2012
1Thyroiditis
08/2022
1Melanoma (Melanoma, Malignant)
08/2022
1Hyperthyroidism
08/2022
1Thyrotoxicosis
08/2022
1Thyroid Nodule (Nodule, Thyroid)
08/2022
1Goiter
08/2022
1Acromegaly
01/2022
1Autoimmune Hypophysitis
03/2018
1Headache (Headaches)
03/2018
1Hyponatremia
03/2018
1Hypopituitarism (Sheehan's Syndrome)
03/2018
1Immune System Diseases (Immune Disorders)
06/2012
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2012
1Dermatomyositis (Dermatopolymyositis)
06/2012
1Adiposis Dolorosa (Dercum's Disease)
06/2012
1Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2012
1Lipodystrophy
06/2012
1Lipomatosis
06/2012
1Multiple Symmetrical Lipomatosis (Lipomatosis, Familial Benign Cervical)
06/2012
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2012
1Memory Disorders (Memory Loss)
01/2012
1Cognitive Dysfunction
01/2012
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
12/2003

Drug/Important Bio-Agent (IBA)

2GlucocorticoidsIBA
10/2018 - 03/2018
2Growth Hormone (Somatotropin)IBA
06/2013 - 01/2012
1CarbimazoleIBA
08/2022
1IpilimumabIBA
08/2022
1NivolumabIBA
08/2022
1Immune Checkpoint InhibitorsIBA
08/2022
1Thyroxine (Levothyroxine)FDA LinkGeneric
08/2022
1lanreotide (Somatuline)FDA Link
01/2022
1CTLA-4 AntigenIBA
03/2018
1Adrenocorticotropic Hormone (ACTH)FDA Link
03/2018
1LigandsIBA
03/2018
1Insulin (Novolin)FDA Link
06/2012
1Complement System Proteins (Complement)IBA
06/2012
1tesamorelinFDA Link
06/2012
1LeptinIBA
06/2012
1Mitochondrial DNA (mtDNA)IBA
06/2012
1Protease Inhibitors (Protease Inhibitor)IBA
06/2012
1Hormones (Hormone)IBA
01/2012
1Anti-Mullerian HormoneIBA
12/2003
1AntralIBA
12/2003

Therapy/Procedure

3Therapeutics
08/2022 - 06/2013
2Immunotherapy
10/2018 - 03/2018
1Activities of Daily Living (ADL)
01/2012